BNTX240920C95000
- 35.60
- +3.16+9.74%
BioNTech Newsroom
Form 144 | BioNTech(BNTX.US) 10% Stockholder Proposes to Sell 3.75 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Sep 17, $BioNTech(BNTX.US)$ 10% Stockholder ATHOS KG intends to sell 30,162 shares of its common stock on Sep 17, with a total market value of approximately $3.75 million.
European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading
US stocks are moving: BioNTech rose about 6.5% at one point and will hold AI Day event in London on October 1st.
On September 17th, BioNTech SE (BNTX.US) rose by about 6.5% to a high of $131.49. On the news front, BioNTech SE and its artificial intelligence company InstaDeep will host the BioNTech 'Innovation Series' AI Day in London, United Kingdom, at 9 a.m. EDT on October 1st. The event will outline BioNTech and InstaDeep's artificial intelligence strategy and capabilities, as well as the application of artificial intelligence in BioNTech's pipeline and internal processes. In addition, several Wall Street
BioNTech Price Target Raised to $150.00/Share From $96.00 by Jefferies
A Quick Look at Today's Ratings for BioNTech(BNTX.US), With a Forecast Between $125 to $171
On Sep 17, major Wall Street analysts update their ratings for $BioNTech(BNTX.US)$, with price targets ranging from $125 to $171.J.P. Morgan analyst Jessica Fye upgrades to a hold rating, and sets
BioNTech Analyst Ratings
BioNTech SE: A Strong Buy on BNT327's Promising Cancer Treatment Prospects and Financial Fortitude
BioNTech to Host AI Day as an Edition of Its Innovation Series on October 1, 2024
Jefferies Upgrades BioNTech SE (BNTX) to a Buy
Express News | JEFFERIES: Biontech's rating has been upgraded from hold to buy, with the target price raised from $96 to $150.
Form 144 | BioNTech(BNTX.US) 10% Stockholder Proposes to Sell 61.7 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Sep 16, $BioNTech(BNTX.US)$ 10% Stockholder ATHOS KG intends to sell 500K shares of its common stock on Sep 16, with a total market value of approximately $61.7 million.
Form 144 | BioNTech(BNTX.US) 10% Stockholder Proposes to Sell 11.34 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Sep 16, $BioNTech(BNTX.US)$ 10% Stockholder ATHOS KG intends to sell 90,000 shares of its common stock on Sep 16, with a total market value of approximately $11.34 million.
DeSantis Administration Cautions Against Pfizer, Moderna MRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions
BioNTech Shares Are Trading Higher B of A Securities and JP Morgan Raised Their Respective Price Targets on the Stock.
Monday's Moving Stocks: RH, BioNTech, and More
Evercore ISI Sticks to Its Hold Rating for BioNTech SE (BNTX)
BioNTech Price Target Raised to $150.00/Share From $125.00 by B of A Securities
BioNTech Is Maintained at Buy by B of A Securities
BioNTech SE (BNTX) Gets a Hold From TD Cowen
BofA Securities Maintains BioNTech(BNTX.US) With Buy Rating, Raises Target Price to $150
BofA Securities analyst Tazeen Ahmad maintains $BioNTech(BNTX.US)$ with a buy rating, and adjusts the target price from $125 to $150.According to TipRanks data, the analyst has a success rate of 53.0%